Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

161
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
161
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

102
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
102
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

246
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
246
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

139
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
139
Pericarditis I: Introduction01:22

Pericarditis I: Introduction

180
Pericarditis is defined as the inflammation of the pericardium, the thin, sac-like membrane surrounding the heart. This condition can cause significant chest pain and other symptoms, often necessitating medical intervention. The pericardium has two layers: the inner visceral layer and the outer parietal layer, separated by a small amount of fluid that reduces friction during heartbeats.Types of PericarditisPericarditis can be classified into several types based on the duration and nature of the...
180
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

365
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
365

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Polymicrobial <i>Streptococcus mitis</i> and <i>Vagococcus fluvialis</i> infective endocarditis.

Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada·2026
Same author

Early Insights on Mavacamten Usage in Canada: A Retrospective Cohort Study of the Mavacamten Patient Support Program.

CJC open·2026
Same author

Percutaneous Mechanical Aspiration of Bioprosthetic Tricuspid Valve Vegetation and Thrombi in Drug Use-Associated Infective Endocarditis.

CJC open·2026
Same author

Guideline-Directed Medical Therapy in Patients After Implantation of Implantable Cardioverter Defibrillators to Improve Outcomes.

CJC open·2026
Same author

Line of block: A simple pacing maneuver to distinguish AV nodal from accessory pathway ventriculoatrial conduction.

Heart rhythm·2026
Same author

First Step in Generalizability and Clinical Application of Ultralow or Fluoroless Cardiac Implantable Electronic Device Implantation Using Ultrasound.

The Canadian journal of cardiology·2026

Related Experiment Video

Updated: Dec 14, 2025

Real-Time Electrocardiogram Monitoring During Treadmill Training in Mice
04:45

Real-Time Electrocardiogram Monitoring During Treadmill Training in Mice

Published on: May 5, 2022

2.8K

COVID-19 and Myocarditis: What Do We Know So Far?

Ashar Pirzada1, Ahmed T Mokhtar1,2, Andrew D Moeller1

  • 1Division of Cardiology, Department of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada.

CJC Open
|July 22, 2020
PubMed
Summary

COVID-19 (coronavirus disease 2019) can cause myocardial injury, with myocarditis being a potential cause. This review provides a framework for diagnosing and treating myocarditis in COVID-19 patients to improve outcomes.

More Related Videos

Noninvasive Assessment of Cardiac Abnormalities in Experimental Autoimmune Myocarditis by Magnetic Resonance Microscopy Imaging in the Mouse
12:24

Noninvasive Assessment of Cardiac Abnormalities in Experimental Autoimmune Myocarditis by Magnetic Resonance Microscopy Imaging in the Mouse

Published on: June 20, 2014

10.2K

Related Experiment Videos

Last Updated: Dec 14, 2025

Real-Time Electrocardiogram Monitoring During Treadmill Training in Mice
04:45

Real-Time Electrocardiogram Monitoring During Treadmill Training in Mice

Published on: May 5, 2022

2.8K
Noninvasive Assessment of Cardiac Abnormalities in Experimental Autoimmune Myocarditis by Magnetic Resonance Microscopy Imaging in the Mouse
12:24

Noninvasive Assessment of Cardiac Abnormalities in Experimental Autoimmune Myocarditis by Magnetic Resonance Microscopy Imaging in the Mouse

Published on: June 20, 2014

10.2K

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Pathology

Background:

  • COVID-19, caused by SARS-CoV-2, is a global pandemic with significant mortality.
  • Myocardial injury is a common complication in COVID-19 patients, occurring in 7%-23% of cases.
  • The role of myocarditis as a cause of myocardial injury in COVID-19 remains debated, despite anecdotal reports.

Purpose of the Study:

  • To review current literature on the association between COVID-19 and myocarditis.
  • To provide clinicians with a practical framework for managing COVID-19-associated myocarditis.
  • To increase awareness of myocarditis as a cause of myocardial injury in COVID-19.

Main Methods:

  • Comprehensive literature review of studies investigating COVID-19 and myocarditis.
  • Synthesis of information on clinical manifestations, diagnostic approaches, and treatment strategies.
  • Analysis of existing data to establish a clinical framework.

Main Results:

  • Myocardial injury is prevalent in COVID-19, linked to increased morbidity and mortality.
  • Evidence suggests myocarditis may be an underrecognized cause of myocardial injury in COVID-19.
  • Current literature highlights the need for heightened clinical suspicion for myocarditis in affected patients.

Conclusions:

  • This review aims to improve clinical outcomes by enhancing suspicion for myocarditis in COVID-19 patients.
  • A structured approach to diagnosis and treatment can aid clinical decision-making.
  • Further research is warranted to elucidate the precise relationship and optimal management of COVID-19-associated myocarditis.